<DOC>
	<DOCNO>NCT00195442</DOCNO>
	<brief_summary>The purpose study investigate effectiveness safety treatment ReFacto condition routine therapy . Furthermore continuous benefit/risk assessment do .</brief_summary>
	<brief_title>Study Evaluating Refacto For Pharmacovigilance</brief_title>
	<detailed_description>Non-interventional study : subject select accord usual clinical practice physician</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Proven diagnosis Hemophilia A Contraindications accord Summary Product Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Hemophilia A</keyword>
</DOC>